Validation of multiple sclerosis diagnoses in the Swedish National Patient Register.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 23 04 2019
accepted: 29 08 2019
pubmed: 8 9 2019
medline: 19 2 2020
entrez: 8 9 2019
Statut: ppublish

Résumé

Population-based registers are widely used in epidemiological studies. We aimed to estimate the validity of multiple sclerosis (MS) diagnoses registered in the Swedish National Patient Register (NPR) by two sequential register-based case-definition algorithms. Prevalent MS patients aged 16-64 years were identified from the in- and specialised out-patient NPR in 2001-2013, using International Classification of Diseases code G35. These identified MS diagnoses were validated through two sequential register-based case-definition algorithms, as the 'gold-standard' reference, by linking individual-level data longitudinally to other nationwide registers. The primary algorithm first sought to corroborate the MS diagnoses with MS-specific information in other nationwide registers. The exploratory secondary algorithm identified individuals with MS-related information in other registers and those who were unable to be followed sufficiently. Through multi-register linkage, we estimated the number of confirmed and uncertain individuals with an MS diagnosis recorded in the NPR. A total of 19,781 individuals (mean age at first visit 45.2 years; 69.5% women) had at least one MS diagnosis recorded in the NPR during 2001-2013. Using the two case-definition algorithms, 92.5% (n = 18,291) of the MS diagnoses recorded in the NPR were confirmed, while 7.5% (n = 1490) remained uncertain. Our findings indicate that a very high percentage of patients coded with an MS diagnosis in the Swedish NPR actually have MS, and supports the use of the NPR as a viable source to identify individuals with an MS diagnosis for population-based research. This exploratory methods paper suggests an alternative novel method to verify individuals' diagnoses in register-based settings.

Identifiants

pubmed: 31493189
doi: 10.1007/s10654-019-00558-7
pii: 10.1007/s10654-019-00558-7
pmc: PMC7010617
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1161-1169

Subventions

Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2007-1762

Références

Handb Clin Neurol. 2014;122:343-69
pubmed: 24507525
J Neurol Neurosurg Psychiatry. 2015 May;86(5):584-5
pubmed: 25412872
Eur J Epidemiol. 2019 Apr;34(4):423-437
pubmed: 30929112
J Neurol. 2017 Jun;264(6):1185-1192
pubmed: 28516332
Eur J Epidemiol. 2016 Feb;31(2):125-36
pubmed: 26769609
Neurology. 2019 Jan 1;92(1):15-16
pubmed: 30381373
Int J Epidemiol. 1996 Apr;25(2):435-42
pubmed: 9119571
Autoimmun Rev. 2014 Apr-May;13(4-5):518-24
pubmed: 24424194
Neurology. 2019 Jan 1;92(1):26-33
pubmed: 30381369
Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48
pubmed: 27640924
Eur J Epidemiol. 2009;24(11):659-67
pubmed: 19504049
Epidemiology. 2019 Mar;30(2):230-233
pubmed: 30721167
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neurology. 2019 Mar 5;92(10):e1016-e1028
pubmed: 30770432
Acta Neurol Scand. 2015;132(199):11-9
pubmed: 26046553
Mult Scler. 2015 Jul;21(8):1045-54
pubmed: 25392338
J Clin Epidemiol. 2011 Aug;64(8):821-9
pubmed: 21194889
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Mult Scler Relat Disord. 2018 Aug;24:48-54
pubmed: 29936325
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Eur J Oncol Nurs. 2016 Jun;22:1-7
pubmed: 27179887
Scand J Public Health. 2011 May;39(3):225-9
pubmed: 21427148
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
Lancet Neurol. 2019 Mar;18(3):269-285
pubmed: 30679040
Mult Scler. 2011 Aug;17(8):901-8
pubmed: 21459810

Auteurs

Chantelle Murley (C)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden. chantelle.murley@ki.se.

Emilie Friberg (E)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.

Jan Hillert (J)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.

Kristina Alexanderson (K)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.

Fei Yang (F)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH